Merck & Co., Inc: all 2,453 studies
Page 10 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067)CompletedNCT01315847Phase 1Results posted
- A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)CompletedNCT01314872Phase 2Results posted
- A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)CompletedNCT01313858Results posted
- A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)CompletedNCT01313520Phase 2Results posted
- Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)CompletedNCT01304498Phase 3Results posted
- MK-0954E Study in Participants With Hypertension (MK-0954E-357)CompletedNCT01302691Phase 3Results posted
- Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036)CompletedNCT01300455Phase 1Results posted
- MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)CompletedNCT01299376Phase 3Results posted
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)CompletedNCT01296412Phase 3Results posted
- Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)CompletedNCT01295827Phase 1Results posted
- A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)CompletedNCT01294800Phase 2Results posted
- A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)CompletedNCT01294709Phase 1Results posted
- A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)TerminatedNCT01294683Phase 3Results posted
- Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)CompletedNCT01293006Phase 1Results posted
- Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-401)CompletedNCT01285076Results posted
- To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung CancerTerminatedNCT01284348Phase 2Results posted
- Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)CompletedNCT01278485Results posted
- A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)CompletedNCT01276847Phase 1Results posted
- Evaluation of the Efficacy and Safety of ADL5945 Once Daily for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer PainCompletedNCT01275755Phase 2Results posted
- A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)CompletedNCT01275170Phase 1Results posted
- Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)TerminatedNCT01274559Phase 3Results posted
- Safety, Tolerability, and Pharmacokinetics of MK-8266 in Elderly Participants With High Blood Pressure (MK-8266-003)CompletedNCT01263314Phase 1Results posted
- A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008).CompletedNCT01254643Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)CompletedNCT01254630Phase 3Results posted
- Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)CompletedNCT01254604Phase 3Results posted
- Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)CompletedNCT01254344Phase 3Results posted
- Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)CompletedNCT01254318Results posted
- Hepatitis B Challenge Dose in Adults (V232-059-10)CompletedNCT01251276Phase 3Results posted
- GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)CompletedNCT01245764Phase 3Results posted
- Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)CompletedNCT01245751Phase 3Results posted
- Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)CompletedNCT01245738Results posted
- Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)CompletedNCT01244035Phase 1Results posted
- A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)TerminatedNCT01243762Phase 1Results posted
- A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)CompletedNCT01241552Phase 3Results posted
- A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)CompletedNCT01235728Phase 1Results posted
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)CompletedNCT01229267Phase 3Results posted
- Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)TerminatedNCT01228019Results posted
- Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)CompletedNCT01227265Phase 3Results posted
- A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)CompletedNCT01225731Phase 2Results posted
- A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)CompletedNCT01217073Phase 2Results posted
- An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)TerminatedNCT01215227Phase 3Results posted
- A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003)CompletedNCT01215188Phase 2Results posted
- Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)CompletedNCT01215175Phase 1Results posted
- A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)CompletedNCT01213316Results posted
- Observational Study to Evaluate the Current Neuromuscular Monitoring Practice Used After Different Types of Surgery, for Which Neuromuscular Blocking Agents Were Used, With or Without Blocking Reversal (P06556)CompletedNCT01213264Results posted
- Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer PainCompletedNCT01207427Phase 2Results posted
- Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).TerminatedNCT01195844Results posted
- A Study on the Effects of a Single Dose of Prednisone on Biomarkers of Allergen Responses in Asthmatics (MK-0000-175)CompletedNCT01193049Phase 1Results posted
- Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid TumorsTerminatedNCT01190644Phase 2Results posted
- Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)CompletedNCT01189890Phase 3Results posted
- Comparison of Safety and Resulting Blood Level Profiles After Administration of a New Boceprevir Tablet Versus Its Current Capsule Formulation for Treatment of Chronic Hepatitis C (P06992)(COMPLETED)CompletedNCT01181804Phase 1Results posted
- Incidence of Incomplete Postoperative Neuromuscular Recovery From Anesthesia (P07535)(Completed)CompletedNCT01181349Results posted
- An Extension Protocol for Subjects Who Were Previously Enrolled in Other Tivantinib (ARQ 197) ProtocolsCompletedNCT01178411Phase 1/2Results posted
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)CompletedNCT01177384Phase 3Results posted
- Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion SettingTerminatedNCT01175707Phase 4Results posted
- TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.CompletedNCT01170221Phase 3Results posted
- A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)CompletedNCT01165320Phase 2Results posted
- A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)TerminatedNCT01155479Phase 3Results posted
- A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)CompletedNCT01155466Phase 3Results posted
- Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Patients Not Receiving Alvimopan in the Premier Perspective DatabaseCompletedNCT01150760Results posted
- Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal InfectionsCompletedNCT01147640Phase 2Results posted
- Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)CompletedNCT01140061Phase 1Results posted
- Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)CompletedNCT01131182Phase 4Results posted
- The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)CompletedNCT01130168Phase 1Results posted
- Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)CompletedNCT01125774Phase 2/3Results posted
- A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053)CompletedNCT01120600Phase 3Results posted
- International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)CompletedNCT01119716Results posted
- Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2)CompletedNCT01119703Results posted
- Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183)CompletedNCT01111851Phase 1Results posted
- Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)CompletedNCT01106287Phase 1Results posted
- Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal ImpairmentTerminatedNCT01104662Phase 4Results posted
- A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)CompletedNCT01104545Phase 1Results posted
- Study of ACE-031 in Subjects With Duchenne Muscular DystrophyTerminatedNCT01099761Phase 2Results posted
- Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)CompletedNCT01098097Results posted
- Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)CompletedNCT01097629Phase 3Results posted
- Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)CompletedNCT01097616Phase 3Results posted
- Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)CompletedNCT01096667Phase 2Results posted
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002)CompletedNCT01096160Phase 1Results posted
- Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)CompletedNCT01093794Phase 1Results posted
- Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)CompletedNCT01092780Phase 1Results posted
- Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)CompletedNCT01088711Phase 1Results posted
- Study of CB-183,315 in Participants With Clostridium Difficile InfectionCompletedNCT01085591Phase 2Results posted
- Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268)CompletedNCT01078246Results posted
- Observational Data Analysis in EuroSIDA (MK-0518-058)CompletedNCT01078233Results posted
- Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)CompletedNCT01078220Results posted
- GARDASIL™ Vaccine Impact in Population Study (V501-033)CompletedNCT01077856Results posted
- A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)CompletedNCT01077804Results posted
- A Study of Adavosertib (MK-1775) in Combination With Topotecan/Cisplatin in Participants With Cervical Cancer (MK-1775-008)TerminatedNCT01076400Phase 1/2Results posted
- Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)CompletedNCT01076088Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)CompletedNCT01076075Phase 3Results posted
- Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)CompletedNCT01075984Phase 1Results posted
- Re-examination Study of EMEND (Aprepitant) (MK-0869-184)CompletedNCT01074255Results posted
- ROTATEQ Reexamination Study (V260-037)CompletedNCT01074242Results posted
- A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)CompletedNCT01073293Phase 3Results posted
- Lipid Management in Clinical Practice (MK-0524A-115)CompletedNCT01071278Results posted
- Safety and Tolerability of Odanacatib (0822-059)CompletedNCT01068262Phase 1Results posted
- Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)CompletedNCT01065766Results posted
- GARDASIL Reexamination Study (V501-059)CompletedNCT01062074Results posted
- Re-examination Study For Varivax (V210-059 AM2)CompletedNCT01062061Results posted
- Early Airway Response to Allergen in Asthmatics (MK-0000-176)CompletedNCT01061333Phase 1Results posted